Official UK procurement notice
NP49426a Transition Medicines · UK public procurement notice
Authority: The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
What is being bought8 lots · detail below
Published requirement descriptionSupply of Transition Medicines to NHS Scotland.
CPV: Pharmaceutical products
How this framework works
From the published notice- Places
- up to 50 suppliers · 16 bids on the busiest of 6 lots (0.3 per place) · 26 appointed
- Framework period
- 2 yrs from 1 Aug 2026
Lots and requirements (8)Procurement structure
8 lots · all with a published value · same evaluation weights on every lotLot #1RSV ImmunisationsAwardedRenewalPublished value£6,065,532
Supply of RSV Monoclonal Antibody Medicines to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line.
Lot #2Analgesics, Anaesthetics & MSD GenericsAwardedRenewalPublished value£2,302,236
Supply of Analgesics, Anaesthetics & MSD Generics medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.
Lot #3Cardiovascular, Respiratory, and HIV MedicinesAwardedRenewalPublished value£4,246,188
Supply of Cardiovascular, Respiratory, and HIV Medicines to NHS Scotland. The Authority intends to award this Lot as
a ranked multi supplier Framework Agreement per product line.
Lot #4Psychiatry and Neurology MedicinesAwardedRenewalPublished value£12,563,056
Supply of Psychiatry and Neurology Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.
Lot #5Cancer MedicinesAwardedRenewalPublished value£43,065,272
Supply of Cancer Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.
Lot #6Gastrointestinal, Endocrine, Nutrition, Blood MedicinesAwardedRenewalPublished value£1,015,748
Supply of Gastrointestinal, Endocrine, Nutrition, Blood Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.
Lot #7Antimicrobial and Genitourinary MedicinesRenewalPublished value£7,351,728
Supply of Antimicrobial and Genitourinary Medicines to NHS Scotland. The Authority intends to award this Lot as
a ranked multi supplier Framework Agreement per product line.
Lot #8Skin MedicinesRenewalPublished value£2,323,408
Supply of skin medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Supply Chain: 5%
- price: 95%
Published award criteria (2)
- Supply Chain: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public
Contracts (Scotland) Regulations 2015.
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL,
PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement.
AND
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
AND
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety
Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
AND
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the
climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP49426a Transition Medicines” is a framework: the contest is a place on its panel, up to 50 suppliers, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 20 May 2026, 11:34 BST
- Last source update
- 23 Sept 2026, 10:55 BST
- Award evaluation window
- 22 Jun 2026 – …
- FTS notice number
2026/S 000-090003- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-069d17Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated values referred to in Section II.1.5 and within all Lots cover the initial contract duration and extension period of the Framework Agreement in respect of each Lot. (SC Ref:843734)
How it was run
Official notice- Appointment period ends
- 22 Jun 2026, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bids opened
- 22 Jun 2026, 12:00 BST
Timeline
22 Jun 2026 → 23 Sept 2026 · 4 dates- Admission / appointment period ends122 days ago · period end, not a bid countdown22 Jun 2026, 12:00 BST
- Bids opened122 days ago22 Jun 2026, 12:00 BST
- Contract starts82 days ago1 Aug 2026, 00:00 BST
- Notice published29 days ago23 Sept 2026, 10:55 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete23 Sept 2026, 10:55 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast6 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
RSV Immunisations
- Signed
- 29 Jul 2026
- Value
- £4,852,424
- Period
- … – 31 Jul 2028
- Status
- active
Analgesics, Anaesthetics & MSD Generics
- Signed
- 27 Jul 2026
- Value
- £2,267,492
- Period
- … – 30 Nov 2028
- Status
- active
Cardiovascular, Respiratory, and HIV Medicines
- Signed
- 27 Jul 2026
- Value
- £4,334,476
- Period
- … – 30 Apr 2028
- Status
- active
Cancer Medicines
- Signed
- 27 Jul 2026
- Value
- £2,514,000
- Period
- … – 31 Jan 2027
- Status
- active
Gastrointestinal, Endocrine, Nutrition, Blood Medicines
- Signed
- 23 Jul 2026
- Value
- £3,127,716
- Period
- … – 31 Jul 2027
- Status
- active
Psychiatry and Neurology Medicines
- Signed
- 18 Jul 2026
- Value
- £8,427,628
- Period
- … – 30 Sept 2028
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · RSV Immunisations | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 2 · Analgesics, Anaesthetics & MSD Generics | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 3 · Cardiovascular, Respiratory, and HIV Medicines | 6bids · 6 electronic · 6 from abroad | 0 | — | — |
| 4 · Psychiatry and Neurology Medicines | 14bids · 14 electronic · 14 from abroad | 0 | — | — |
| 5 · Cancer Medicines | 16bids · 16 electronic · 16 from abroad | 0 | — | — |
| 6 · Gastrointestinal, Endocrine, Nutrition, Blood Medicines | 7bids · 7 electronic · 7 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
26 commercial parties on the notice- Aventis Pharma Ltd Trading As SanofiFramework contractor
- Bowmed Ibisqus LimitedFramework contractor
- Brancaster Pharma LimitedFramework contractor
- CST Pharma LtdFramework contractor
- Celix Pharma Ltd.Framework contractor
- Colonis Pharma LtdFramework contractor
- Consilient Health LtdFramework contractor
- Crescent Pharma LimitedFramework contractor
- Dr Reddy's Laboratories (UK) LtdFramework contractor
- Focus Pharmaceuticals LtdFramework contractor
Show 16 more suppliers
- Fresenius Kabi LimitedFramework contractor
- Gerot Lannach UK LtdFramework contractor
- GlaxoSmithKlineFramework contractor
- Janssen-Cilag LtdFramework contractor
- MSN LabsFramework contractor
- Martindale PharmaFramework contractor
- Merck Sharp & Dohme UK LtdFramework contractor
- Novumgen LimitedFramework contractor
- Orifarm UKFramework contractor
- Pfizer LtdFramework contractor
- Ranbaxy (UK) LtdFramework contractor
- Reig Jofre UKFramework contractor
- STADA UK - Thornton & RossFramework contractor
- Teva UK LtdFramework contractor
- Viatris UK Healthcare LtdFramework contractor
- ZentivaFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.